(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.05%) $82.59
(1.82%) $2.07
(-0.67%) $2 342.00
(-1.50%) $27.25
(-0.15%) $960.10
(0.19%) $0.934
(0.28%) $11.01
(0.14%) $0.797
(0.01%) $93.31
0.00% HKD 0.730
Live Chart Being Loaded With Signals
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally...
Stats | |
---|---|
Tagesvolumen | 12 500.00 |
Durchschnittsvolumen | 53 974.00 |
Marktkapitalisierung | 288.39M |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0.0191 ( 2017-05-31 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -2.70 |
ATR14 | HKD0 (0.00%) |
PuraPharm Corp Ltd Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
PuraPharm Corp Ltd Finanzdaten
Annual | 2023 |
Umsatz: | HKD406.86M |
Bruttogewinn: | HKD214.85M (52.81 %) |
EPS: | HKD-0.270 |
FY | 2023 |
Umsatz: | HKD406.86M |
Bruttogewinn: | HKD214.85M (52.81 %) |
EPS: | HKD-0.270 |
FY | 2022 |
Umsatz: | HKD448.07M |
Bruttogewinn: | HKD260.59M (58.16 %) |
EPS: | HKD-0.300 |
FY | 2021 |
Umsatz: | HKD659.59M |
Bruttogewinn: | HKD423.35M (64.18 %) |
EPS: | HKD-0.329 |
Financial Reports:
No articles found.
PuraPharm Corp Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0840 | 2016-05-19 |
Last Dividend | HKD0.0191 | 2017-05-31 |
Next Dividend | HKD0 | N/A |
Payout Date | 2017-06-23 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.103 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.73 | -- |
Div. Sustainability Score | 0.0346 | |
Div.Growth Potential Score | 1.387 | |
Div. Directional Score | 0.711 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9928.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
2180.HK | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% | |
1181.HK | Ex Dividend Knight | 2023-09-13 | Annually | 0 | 0.00% | |
0257.HK | Ex Dividend Junior | 2023-09-25 | Semi-Annually | 0 | 0.00% | |
3888.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1755.HK | Ex Dividend Knight | 2023-07-03 | Annually | 0 | 0.00% | |
0798.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
2338.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1313.HK | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
0373.HK | Ex Dividend Junior | 2023-05-04 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.261 | 1.500 | -5.21 | -7.82 | [0 - 0.5] |
returnOnAssetsTTM | -0.126 | 1.200 | -4.19 | -5.03 | [0 - 0.3] |
returnOnEquityTTM | -0.574 | 1.500 | -7.49 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.612 | 0.800 | -1.939 | -1.552 | [1 - 3] |
quickRatioTTM | 0.225 | 0.800 | -3.38 | -2.70 | [0.8 - 2.5] |
cashRatioTTM | 0.0827 | 1.500 | -0.652 | -0.978 | [0.2 - 2] |
debtRatioTTM | 0.478 | -1.500 | 2.04 | -3.06 | [0 - 0.6] |
interestCoverageTTM | -1.798 | 1.000 | -1.777 | -1.777 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.137 | 2.00 | 9.95 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0818 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.63 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.528 | 1.000 | 4.53 | 4.53 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.121 | 1.000 | -4.42 | -4.42 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.134 | 1.000 | -0.367 | -0.367 | [0.2 - 2] |
assetTurnoverTTM | 0.482 | 0.800 | -0.119 | -0.0956 | [0.5 - 2] |
Total Score | 0.0346 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.72 | 1.000 | -0.376 | 0 | [1 - 100] |
returnOnEquityTTM | -0.574 | 2.50 | -4.81 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0818 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.137 | 2.00 | 9.95 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00588 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 1.387 |
PuraPharm Corp Ltd
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.